Skip to search formSkip to main contentSkip to account menu

metastatic pancreas cancer

Known as: Metastatic Tumor to the Pancreas, pancreatic cancer, metastatic, Secondary Malignant Neoplasm to the Pancreas 
A malignant neoplasm that has spread to the pancreas from another anatomic site. Representative examples include metastatic carcinomas from the… 
National Institutes of Health

Related topics

Related topics

7 relations
Exocrine pancreasGastrointestinal systemNeoplasm MetastasisNeoplastic Cell

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
A randomized double-blind phase 2 study of ruxolitinib (RUX) or placebo (PBO) with capecitabine (CAPE) as second-line therapy in patients (pts) with metastatic pancreatic cancer (mPC).
4000 Background: Local and systemic inflammation (INFL) are hallmarks of cancer, including PC, that adversely impact prognosis… 
Highly Cited
2012
Highly Cited
2012
An LED light source and novel fluorophore combinations improve fluorescence laparoscopic detection of metastatic pancreatic cancer in orthotopic mouse models.
Highly Cited
2006
Highly Cited
2006
Phase II study of fixed dose rate gemcitabine with cisplatin for metastatic adenocarcinoma of the pancreas.
PURPOSE Although gemcitabine remains the standard of care for patients with advanced pancreatic cancer, additional improvements… 
Highly Cited
2005
Highly Cited
2005
A Phase I Study of Combination Chemotherapy with Gemcitabine and Oral S-1 for Advanced Pancreatic Cancer
Objective: The aim of this study was to determine the maximum-tolerated dose and dose-limiting toxicity (DLT) of combination… 
Highly Cited
2004
Highly Cited
2004
Claudin 4 Protein Expression in Primary and Metastatic Pancreatic Cancer
We performed a comprehensive immunohistochemical evaluation of claudin 4 protein expression in paraffin-embedded tissue samples… 
Highly Cited
2004
Highly Cited
2004
Combined Irinotecan and Oxaliplatin in Patients with Advanced Pre-Treated Pancreatic Cancer
Objectives: This study evaluated the clinical activity and toxicity of combination chemotherapy with irinotecan and oxaliplatin… 
2004
2004
Salvage Chemotherapy with Mitomycin, Docetaxel, and Irinotecan (MDI Regimen) in Metastatic Pancreatic Adenocarcinoma: A Phase I and II Trial
Background: This study evaluates the maximum tolerated dose (MTD) and activity of mitomycin, docetaxel, and irinotecan (MDI… 
Highly Cited
2002
Highly Cited
2002
Irinotecan plus gemcitabine induces both radiographic and CA 19-9 tumor marker responses in patients with previously untreated advanced pancreatic cancer.
PURPOSE This phase II, multicenter, open-label, single-arm study evaluated the efficacy and safety of irinotecan and gemcitabine… 
Highly Cited
2000
Highly Cited
2000
A Phase II Study of Gemcitabine and 5-Fluorouracil in Metastatic Pancreatic Cancer: An Eastern Cooperative Oncology Group Study (E3296)
Gemcitabine has recently been compared favorably to 5-fluorouracil (5-FU) as the standard chemotherapy for advanced pancreas… 
Highly Cited
1996
Highly Cited
1996
Gene therapy of metastatic pancreas cancer with intraperitoneal injections of concentrated retroviral herpes simplex thymidine kinase vector supernatant and ganciclovir.
OBJECTIVE The objective of this study was to determine the efficacy of intraperitoneal (IP) injections of a new concentrated… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)